Nuvalent Inc (NUVL)
70.34
-2.15
(-2.97%)
USD |
NASDAQ |
May 03, 16:00
70.34
0.00 (0.00%)
After-Hours: 20:00
Nuvalent Shares Outstanding: 64.07M for Jan. 31, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
January 31, 2024 | 64.07M |
December 31, 2023 | 64.07M |
October 31, 2023 | 62.63M |
October 19, 2023 | 62.38M |
September 30, 2023 | 57.17M |
July 31, 2023 | 57.02M |
June 30, 2023 | 56.96M |
April 28, 2023 | 56.82M |
April 18, 2023 | 56.77M |
March 31, 2023 | 56.75M |
February 28, 2023 | 56.70M |
December 31, 2022 | 56.67M |
November 03, 2022 | 56.44M |
September 30, 2022 | 48.49M |
Date | Value |
---|---|
July 29, 2022 | 48.41M |
June 30, 2022 | 48.34M |
April 29, 2022 | 48.31M |
April 19, 2022 | 48.31M |
March 31, 2022 | 48.31M |
February 28, 2022 | 48.31M |
December 31, 2021 | 48.30M |
October 31, 2021 | 48.28M |
September 30, 2021 | 48.28M |
August 31, 2021 | 48.28M |
August 02, 2021 | 48.28M |
July 29, 2021 | 46.82M |
July 26, 2021 | 45.97M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
45.97M
Minimum
Jul 26 2021
64.07M
Maximum
Jan 31 2024
53.23M
Average
48.49M
Median
Sep 30 2022
Shares Outstanding Benchmarks
Geron Corp | 546.06M |
Verastem Inc | 25.31M |
Karyopharm Therapeutics Inc | 115.07M |
Syndax Pharmaceuticals Inc | 84.98M |
AnaptysBio Inc | 26.76M |